...
首页> 外文期刊>JAMA oncology. >Efficacy of capecitabine plus irinotecan vs irinotecan monotherapy as second-line treatment in patients with advanced gallbladder cancer: a multicenter phase 2 randomized clinical trial (GB-SELECT) (vol 7, pg 436, 2021)
【24h】

Efficacy of capecitabine plus irinotecan vs irinotecan monotherapy as second-line treatment in patients with advanced gallbladder cancer: a multicenter phase 2 randomized clinical trial (GB-SELECT) (vol 7, pg 436, 2021)

机译:卡培他滨加伊立替康与伊立替康单一疗法作为二线治疗的疗效在晚期胆囊癌患者中:多中心2期随机临床试验(GB-SELECT)(GB-SELECT)(第7卷,PG 436,2021)

获取原文
获取原文并翻译 | 示例

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号